Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2013

May 16, 2013

30826_dirs_2013-05-16_55fc7849-cebe-4495-8e19-bf29f896e98b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2013-05-14

Reporting Person: HERLIHY WALTER C (Director, PRESIDENT, CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-05-14 Common Stock S 38486 $8.976 Disposed 549307 Direct
2013-05-14 Common Stock G 10000 Disposed 539307 Direct
2013-05-15 Common Stock S 1514 $8.85 Disposed 537793 Direct

Footnotes

F1: $8.9760 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.90 to $9.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.